Podcasts

Articles

Webinars

Peer-Reviewed

Videos

American Thoracic Society

Abstracts from the ATS 2021 International Conference addressed patient decision-making frameworks for seeking care for chronic obstructive pulmonary disease (COPD) and tactics used to assist hospitals in implementing readmission reduction plans.

ATS 2021 Abstracts Identify Factors Influencing Hospitalization Risks for COPD

Abstracts from the ATS 2021 International Conference provided some insight into tactics that could improve the effectiveness of pulmonary rehabilitation programs in patients with chronic obstructive pulmonary disease (COPD).

What Factors Can Help Improve the Effectiveness of Pulmonary Rehabilitation in COPD?

Posters presented at the ATS 2021 International Conference noted some ways clinical characteristics associated with patients with chronic obstructive pulmonary disease (COPD) differ based on different demographics and smoking status.

Characteristics of COPD Vary Among Different Demographics and Smoking Statuses

It is already known that dual-eligible older adults are at an increased risk for death in the year following a stay in the intensive care unit (ICU), but it previously wasn't known whether dual-eligible status is linked with functional decline after an ICU stay.

After an ICU Stay, Dual-Eligible Beneficiaries Have More Disability

Patients with refractory or unexplained chronic cough are concerned about how they appear to others, and it takes them many years to get diagnosed, according to posters presented at the American Thoracic Society 2021 International Conference.

Posters Examine Impact of Chronic Cough on Quality of Life, Diagnosis Delays

Stephanie Lovinsky-Desir, MD, MS, describes her research on the impact of environmental factors on respiratory health among children.

Dr Stephanie Lovinsky-Desir Discusses Her Research on Environmental Factors, Exercise, and Respiratory Health

Farrah Kheradmand, MD, explains the effects of vaping duration on lung function. 

Dr Farrah Kheradmand Describes How Vaping Duration Impacts Associated Lung Injuries

Fernando Holguin, MD, describes the relationship between comorbid metabolic syndrome and pulmonary disease. 

Dr Fernando Holguin Offers Insights on Recognizing Metabolic Syndrome Risk in Pulmonary Disease Management 

During the ATS 2021 International Conference, several studies shed new light on 2 asthma biologics.

Studies Give Additional Info on Tezepelumab, Dupilumab Biologics for Asthma

The e-cigarette or vaping product use–associated lung injury epidemic helped jumpstart the regulation of flavored e-cigarettes, said Laura Crotty Alexander, MD, ATSF.